SANTA MONICA, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Kite Pharma, Inc. (NASDAQ: KITE) (“Kite”) and Cell Design Labs, Inc. today announced a research collaboration and license agreement to develop ...
Kite Pharma and Cell Design Labs said today they will partner to develop next-generation, precision-controlled chimeric antigen receptor (CAR) T-cell immunotherapy candidates using Cell Design Labs’ ...
Aecon and Skyport are launching a contest to design Bermudian kites, with the winning designs set to “be incorporated into actual kites that will be suspended from the ceilings in the new terminal.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback